HOSPICES CIVILS DE LYON

🇫🇷France

Country: 🇫🇷France

Ownership: -

Established: 1796-01-01

Employees: 10K

Market Cap: -

Website: http://www.chu-lyon.fr

Clinical Trials

Predictive Factors and Autonomy Level Change

Not Applicable

Recruiting

Conditions: Memory Impairment

Interventions: Other: The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6

First Posted Date: 2014-11-27

Last Posted Date: 2021-06-28

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 10860

Registration Number: NCT02302482

Locations: 🇫🇷
Hospices Civils de Lyon - Hôpital des Charpennes, Lyon, France
🇫🇷
Hôpital Dugoujon, Caluire-et-Cuire, France

Quantitative Prostate Cancer Contrast-enhanced Ultrasound

Not Applicable

Conditions: Prostate Cancer

Interventions: Device: biopsy sample performed after the SonoVue® injection

First Posted Date: 2014-11-20

Last Posted Date: 2018-08-31

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 130

Registration Number: NCT02295449

Locations: 🇫🇷
Assistance Publique Hôpitaux de Paris - Hôpital Necker - Service de Radiologie adultes, Paris, France
🇫🇷
CHU de Bordeaux - Hôpital Pellegrin - Service d'imagerie diagnostique et interventionnelle de l'adulte, Bordeaux, France
🇫🇷
Hospices Civils de Lyon - Hopital Edouard Herriot, Lyon, France

Multicenter Trial Comparing One-step Partial Caries Removal to Complete Caries Removal for the Treatment of Deep Carious Lesions in Permanent Teeth. (DECAT : DEep CAries Treatment).

Phase 3

Conditions: Deep Caries

Interventions: Procedure: A one-step partial caries removal procedure for the treatment of deep carious lesions in posterior permanent teeth.
Procedure: A complete caries removal procedure for the treatment of deep carious lesions in posterior permanent teeth.
Device: The application of an antibacterial dental adhesive (ClearfilTM SE Protect, Kuraray Dental).
Device: The application of a conventional dental adhesive (ClearfilTM SE Bond, Kuraray Dental)

First Posted Date: 2014-11-07

Last Posted Date: 2016-09-29

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 464

Registration Number: NCT02286388

Locations: 🇫🇷
Hôpital Estaing, Clermont Ferrand, France
🇫🇷
CHU Lille, Lille, France
🇫🇷
CHRU Rennes, Rennes, France

and more 11 locations

Impact of Salpingectomy on Ovarian Reserve

Not Applicable

Completed

Conditions: Laparoscopic Salpingectomy

Interventions: Device: Bipolar electric energy
Device: ultrasound energy

First Posted Date: 2014-11-06

Last Posted Date: 2021-04-02

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 96

Registration Number: NCT02284711

Locations: 🇫🇷
Hospices Civils de Lyon - HFME, Lyon, France

Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Biological: Bone marrow sampling

First Posted Date: 2014-11-04

Last Posted Date: 2018-02-22

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 17

Registration Number: NCT02282644

Locations: 🇫🇷
Hôpital Edouard Herriot - service d'urologie, Lyon, France

Medical and Economic Evaluation for Intermediate-risk Prostate Cancer

Not Applicable

Conditions: Prostate Cancer

Interventions: Radiation: Brachytherapy boost with external beam radiotherapy
Radiation: Exclusive external beam radiotherapy

First Posted Date: 2014-10-22

Last Posted Date: 2016-09-13

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 298

Registration Number: NCT02271659

Locations: 🇫🇷
CHU Jean MINJOZ, Besançon, France
🇫🇷
Clinique Tivoli, Bordeaux, France
🇫🇷
Institut Bergonie, Bordeaux, France

and more 26 locations

Study Evaluating the Efficacy of Aflibercept for the Treatment of NVCI in Young Patients

Phase 2

Completed

Conditions: Idiopathic Choroidal Neovascularization

Interventions: Drug: aflibercept

First Posted Date: 2014-10-06

Last Posted Date: 2019-07-23

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 20

Registration Number: NCT02257502

Locations: 🇫🇷
Hospices Civils de Lyon - Hôpital de la Croix-Rousse, Lyon, France

Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition

Not Applicable

Conditions: Cancer
Infection

Interventions: Drug: Placebo
Device: Taurolock

First Posted Date: 2014-10-02

Last Posted Date: 2016-10-28

Lead Sponsor: Hospices Civils de Lyon

Target Recruit Count: 70

Registration Number: NCT02255318

Locations: 🇫🇷
Hôpital Edouard Herriot, France, Lyon, France
🇫🇷
Groupement Hospitalier Lyon Sud, Pierre Bénite, France
🇫🇷
Hôpital de la Croix Rousse, France, France